Literature DB >> 16623066

Roots of prostate cancer in African-American men.

Folakemi T Odedina1, J Olufemi Ogunbiyi, Flora A M Ukoli.   

Abstract

To fully understand the role of genetics and environment (biotic, abiotic and sociocultural) in the prostate cancer disparity experienced by African-American men, this paper examined the rates of prostate cancer among African-American men and one of their ancestral populations in west Africa. Data sources were from the World Health Organization (WHO) and reported hospital records in the literature. Based on the WHO's worldwide cancer data, west African men have much lower prostate cancer incidence and mortality compared to African-American men. For example, compared to Nigerian men, African-American men are >10 times likely to develop prostate cancer and 3.5 times likely to die from the disease. However, contrary to the global ranking by WHO, there is documented evidence in the literature indicating that prostate cancer in at least one west African country is similar to rates found in the United States and in Caribbean Islands. To better address prostate cancer disparity, future studies should study populations and subgroups from central and west Africa, the original source population for African Americans.

Entities:  

Mesh:

Year:  2006        PMID: 16623066      PMCID: PMC2569237     

Source DB:  PubMed          Journal:  J Natl Med Assoc        ISSN: 0027-9684            Impact factor:   1.798


  18 in total

1.  Y chromosome STR haplotypes and the genetic structure of U.S. populations of African, European, and Hispanic ancestry.

Authors:  Manfred Kayser; Silke Brauer; Hiltrud Schädlich; Mechthild Prinz; Mark A Batzer; Peter A Zimmerman; B A Boatin; Mark Stoneking
Journal:  Genome Res       Date:  2003-04       Impact factor: 9.043

2.  CYP3A4-V and prostate cancer in African Americans: causal or confounding association because of population stratification?

Authors:  Rick A Kittles; Weidong Chen; Ramesh K Panguluri; Chiledum Ahaghotu; Aaron Jackson; Clement A Adebamowo; Robin Griffin; Tyisha Williams; Flora Ukoli; Lucile Adams-Campbell; John Kwagyan; William Isaacs; Vincent Freeman; Georgia M Dunston
Journal:  Hum Genet       Date:  2002-05-07       Impact factor: 4.132

3.  Characterization of prostatic carcinoma among blacks: a comparison between a low-incidence area, Ibadan, Nigeria, and a high-incidence area, Washington, DC.

Authors:  M A Jackson; J Kovi; M Y Heshmat; T A Ogunmuyiwa; G W Jones; A O Williams; E C Christian; E O Nkposong; M S Rao; A G Jackson; B S Ahluwalia
Journal:  Prostate       Date:  1980       Impact factor: 4.104

4.  Characterization of prostatic carcinoma among blacks: a continuation report.

Authors:  M A Jackson; B S Ahluwalia; J Herson; M Y Heshmat; A G Jackson; G W Jones; S K Kapoor; J Kennedy; J Kovi; A O Lucas; E O Nkposong; E Olisa; A O Williams
Journal:  Cancer Treat Rep       Date:  1977 Mar-Apr

5.  Prostatic carcinoma in Nigeria: a 10-year retrospective study.

Authors:  F N Udeh
Journal:  Int Urol Nephrol       Date:  1981       Impact factor: 2.370

6.  Benign prostatic hyperplasia and prostate carcinoma in native Africans.

Authors:  D Dawam; A H Rafindadi; G D Kalayi
Journal:  BJU Int       Date:  2000-06       Impact factor: 5.588

7.  Histopathological review of prostatic diseases in Kano, Nigeria.

Authors:  A Z Mohammed; S U Alhassan; S T Edino; O Ochicha
Journal:  Niger Postgrad Med J       Date:  2003-03

Review 8.  Prostate cancer epidemiology.

Authors:  Henrik Grönberg
Journal:  Lancet       Date:  2003-03-08       Impact factor: 79.321

9.  Prevalence of elevated serum prostate-specific antigen in rural Nigeria.

Authors:  Flora Ukoli; Usifo Osime; Folasade Akereyeni; Osazuwa Okunzuwa; Rick Kittles; Lucile Adams-Campbell
Journal:  Int J Urol       Date:  2003-06       Impact factor: 3.369

10.  Epidemiologic aspects of latent and clinically manifest carcinoma of the prostate.

Authors:  G Dhom
Journal:  J Cancer Res Clin Oncol       Date:  1983       Impact factor: 4.553

View more
  25 in total

1.  Physalis Mottle Virus-like Nanoparticles for Targeted Cancer Imaging.

Authors:  He Hu; Hema Masarapu; Yuning Gu; Yifan Zhang; Xin Yu; Nicole F Steinmetz
Journal:  ACS Appl Mater Interfaces       Date:  2019-05-10       Impact factor: 9.229

2.  Global prostate cancer incidence and the migration, settlement, and admixture history of the Northern Europeans.

Authors:  Kristin Gunderson; Christopher Y Wang; Ruoxiang Wang
Journal:  Cancer Epidemiol       Date:  2010-12-16       Impact factor: 2.984

3.  Within-group differences between native-born and foreign-born Black men on prostate cancer risk reduction and early detection practices.

Authors:  Folakemi T Odedina; Getachew Dagne; Margareth LaRose-Pierre; John Scrivens; Frank Emanuel; Angela Adams; Shannon Pressey; Oladapo Odedina
Journal:  J Immigr Minor Health       Date:  2011-12

4.  Prostate cancer cognitive-behavioral factors in a West African population.

Authors:  Folakemi T Odedina; Daohai Yu; Titilola O Akinremi; R Renee Reams; Matthew L Freedman; Nagi Kumar
Journal:  J Immigr Minor Health       Date:  2008-12-04

5.  Dysprosium-Modified Tobacco Mosaic Virus Nanoparticles for Ultra-High-Field Magnetic Resonance and Near-Infrared Fluorescence Imaging of Prostate Cancer.

Authors:  He Hu; Yifan Zhang; Sourabh Shukla; Yuning Gu; Xin Yu; Nicole F Steinmetz
Journal:  ACS Nano       Date:  2017-09-06       Impact factor: 15.881

6.  Comparing dietary and other lifestyle factors among immigrant Nigerian men living in the US and indigenous men from Nigeria: potential implications for prostate cancer risk reduction.

Authors:  Nagi B Kumar; Daohai Yu; Titilola O Akinremi; Folakemi T Odedina
Journal:  J Immigr Minor Health       Date:  2009-02-19

7.  Xenoestrogen interference with nongenomic signaling actions of physiological estrogens in endocrine cancer cells.

Authors:  Cheryl S Watson; Luke Koong; Yow-Jiun Jeng; Rene Vinas
Journal:  Steroids       Date:  2018-07-20       Impact factor: 2.668

Review 8.  Gene interference strategies as a new tool for the treatment of prostate cancer.

Authors:  Mariarosaria Boccellino; Concetta Alaia; Gabriella Misso; Alessia Maria Cossu; Gaetano Facchini; Raffaele Piscitelli; Lucio Quagliuolo; Michele Caraglia
Journal:  Endocrine       Date:  2015-06-07       Impact factor: 3.925

9.  Early results of prostate cancer radiation therapy: an analysis with emphasis on research strategies to improve treatment delivery and outcomes.

Authors:  Kosj Yamoah; Kwamena Beecham; Sarah E Hegarty; Terry Hyslop; Timothy Showalter; Joel Yarney
Journal:  BMC Cancer       Date:  2013-01-16       Impact factor: 4.430

10.  Do evolutionary life-history trade-offs influence prostate cancer risk? a review of population variation in testosterone levels and prostate cancer disparities.

Authors:  Louis Calistro Alvarado
Journal:  Evol Appl       Date:  2012-12-11       Impact factor: 5.183

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.